Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

A rare tumor caused unusual hormone production leading to Cushing syndrome.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Electrochemotherapy successfully treated skin tumors in cats without recurrence.

Kaposi's sarcoma lesions might originate from benign tissue changes.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

The PML protein helps prevent skin cancer in mice.

CS12192 effectively treats alopecia areata with better safety than current options.

Thyroid hormone receptors are essential for hair growth and wound healing.

UC.145 may be a new biomarker for predicting gastric cancer.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

lncRNA MTC helps goat skin cells grow and may aid hair growth by controlling proteins linked to cell growth.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Transglutaminases work through a ping-pong mechanism, and human plasma and platelet transglutaminases have similar catalytic subunits.

A CCS patient with severe complications was successfully treated using combined therapies.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

Cats can have hypersomatotropism without diabetes, suggesting current diagnosis methods may miss cases.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.